Lunai Bioworks
LNAI
56 hedge funds and large institutions have $18.5M invested in Lunai Bioworks in 2024 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 33 increasing their positions, 7 reducing their positions, and 4 closing their positions.
371% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 7
175% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 4
159% more capital invested
Capital invested by funds: $7.13M → $18.5M (+$11.4M)
14% more funds holding
Funds holding: 49 → 56 (+7)
0.05% more ownership
Funds ownership: 0.13% → 0.17% (+0.05%)
15% less call options, than puts
Call options by funds: $35K | Put options by funds: $41K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$2.4M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$631K |
| 3 |
State Street
Boston,
Massachusetts
|
+$615K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$595K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$244K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HSBC Holdings
London,
United Kingdom
|
-$34.6K |
| 2 |
New York State Common Retirement Fund
Albany,
New York
|
-$11.8K |
| 3 |
Jane Street
New York
|
-$8.76K |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$8.19K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$7.5K |
LNAI Hedge Fund Activity: Q4 2024 in Review
56 of the 7,606 institutional investors tracked by Wall St. Rank reported a position in Lunai Bioworks (LNAI) for Q4 2024, worth a combined $18.5M — up 159% from $7.13M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new LNAI positions and 4 closed out — a net gain of 7 holders — while 33 added to existing stakes and 7 trimmed.
The largest buyer was BlackRock, adding an estimated $2.4M. The largest seller was HSBC Holdings, cutting an estimated $34.6K.
- 56 institutional investors held Lunai Bioworks (LNAI) as of Q4 2024, up from 49 in Q3 2024.
- Funds reported $18.5M of Lunai Bioworks stock for Q4 2024, up 159% quarter-over-quarter.
- 11 funds opened new Lunai Bioworks positions in Q4 2024 and 4 closed out, a net change of +7 holders.
- The largest Lunai Bioworks buyer in Q4 2024 was BlackRock, an estimated $2.4M added.
- The largest Lunai Bioworks seller in Q4 2024 was HSBC Holdings, an estimated $34.6K sold.
Based on aggregated 13F filings for Q4 2024.